Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL/LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress
14 juin 2024 07h30 HE
|
Wugen
Wugen Presents Data at European Hematology Association (EHA) 2024 Hybrid Congress
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants
14 juin 2024 07h01 HE
|
Invivyd
Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current...
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
14 juin 2024 07h00 HE
|
Renalytix plc
LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination ("LCD")...
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
14 juin 2024 07h00 HE
|
Bio-Path Holdings, Inc.
HOUSTON, June 14, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
14 juin 2024 07h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics to Present Three Clinical Data Updates on obe-cel at EHA
Shandong (Dong'e) Traditional Chinese Medicine Cultural Tourism Experience Week Held in Liaocheng City
14 juin 2024 06h58 HE
|
Liaocheng Municipal People's Government
LIAOCHENG, China, June 14, 2024 (GLOBE NEWSWIRE) -- On June 4-10, the Shandong (Dong'e) Traditional Chinese Medicine Cultural Tourism Experience Week took place in Dong'e County, Liaocheng City,...
Carotenoids Market Size, Share, Industry Trends & Growth Analysis and Forecast [2029]
14 juin 2024 04h05 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, June 14, 2024 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the carotenoids market is projected to reach USD 3.4 billion by 2029 from USD 2.5 billion by 2024, at a CAGR of 6.3% during...
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
14 juin 2024 03h00 HE
|
Beam Therapeutics
MADRID, June 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported data highlighting...
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
14 juin 2024 03h00 HE
|
Samsung Bioepis
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congre
Updated: Breast Surgery Collaborative Community issues consensus statement on breast implant capsulectomy definitions and management
13 juin 2024 16h11 HE
|
American Society of Plastic Surgeons
Arlington Heights, Ill, June 13, 2024 (GLOBE NEWSWIRE) -- A consensus statement on the terminology and management of breast implant capsules issued by the Breast Surgery Collaborative Community...